Carl Zeiss Meditec to review guidance after difficult Q1
Carl Zeiss Meditec has had a difficult start to its new 2025/26 fiscal year. Q1 revenue declined by 4.7 percent year on year to €467 million and EBITA margin fell by 5.4 percentage points to 1.7 percent. The company attributed its difficulties to several factors, including currency headwinds, strong deliveries ...
Already an Eyewear Intelligence subscriber? Sign in here.
Subscribe today
Buying a membership today will give you:
- Unlimited access to ewintelligence.com - all insight and analysis available online
- Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
- Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
- Case studies and best practices on business challenges
- Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
- Access to over 11,500 articles and analyses in the archive
- Personal library to save articles and track your key content
- Powerful search and intuitive navigation
- Organisation-wide access across offices, people and devices
To continue reading this article register now.